The above tumours were initially considered benign, but angiomyolipoma and LAM have recently been reclassified as “low grade, destructive, metastasizing neoplasms” characterised by α-smooth muscle actin (α-SMA), vimentin, desmin and melanoma gp100 (HMB45) markers. Here, PMEL is linked to neoplasm.